Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sirolimus gel for phymatous rosacea
ChiCTR2600122725Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rosacea comparing 0.2% sirolimus gel with Placebo gel (2 arms). Primary endpoints: AI-driven Phymatous Rosacea Score (AI-PRS), Phymatous volume and 3 more. Started Apr 2026; status: recruiting.
02
Drugs
sirolimus
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2600122725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122725.